Montag A & Associates Inc Viatris Inc Transaction History

Montag A & Associates Inc

$1.97 Billion
Q2 2024

A detailed history of Montag A & Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 401 shares of VTRS stock, worth $4,607. This represents 0.0% of its overall portfolio holdings.

Number of Shares

401

Previous 582 31.1%

Holding current value

$4,607

Previous $6,000 33.33%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$10.05 - $12.02 $1,819 - $2,175	-181 Reduced 31.1%	401 $4,000
Q4 2023 Feb 07, 2024	SELL	$8.77 - $10.85 $1,508 - $1,866	-172 Reduced 22.81%	582 $6,000
Q3 2023 Nov 09, 2023	SELL	$9.59 - $11.35 $1,189 - $1,407	-124 Reduced 14.12%	754 $7,000
Q1 2023 May 11, 2023	SELL	$9.2 - $12.26 $41,206 - $54,912	-4,479 Reduced 83.61%	878 $8,000
Q4 2022 Feb 02, 2023	SELL	$8.72 - $11.56 $2,659 - $3,525	-305 Reduced 5.39%	5,357 $59,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $3,035 - $3,984	-358 Reduced 5.95%	5,662 $48,000
Q2 2022 Aug 10, 2022	SELL	$9.95 - $12.27 $7,770 - $9,582	-781 Reduced 11.48%	6,020 $63,000
Q4 2021 Feb 09, 2022	SELL	$12.09 - $14.68 $18,848 - $22,886	-1,559 Reduced 18.65%	6,801 $92,000
Q3 2021 Nov 08, 2021	SELL	$13.25 - $15.13 $23,532 - $26,870	-1,776 Reduced 17.52%	8,360 $113,000
Q2 2021 Aug 03, 2021	SELL	$12.97 - $16.15 $10,752 - $13,388	-829 Reduced 7.56%	10,136 $145,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $74,812 - $102,062	-5,505 Reduced 33.42%	10,965 $153,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $235,521 - $308,647	16,470 New	16,470 $309,000

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

969M

Call Options Held

2.63M

Put Options Held

2.15M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Account

Montag A & Associates Inc Viatris Inc Transaction History